References
- Hochberg MC, Ross PD, Black D, et al. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 1999; 42(6): 1246–54
- Cummings SR, Palermo L, Browner W, et al. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA 2000; 283(10): 1318–21
- American Medical Association. Managing osteoporosis. Chicago: American Medical Association, 1999: 1–20
- National Institutes of Health. Consensus Development Conference Statement: osteoporosis prevention, diagnosis, and therapy. National Institutes of Health, 2000: 1–29